A national approach to pediatric sepsis surveillance by Hsu, H.E. et al.
A National Approach to Pediatric
Sepsis Surveillance
Heather E. Hsu, MD, MPH,a Francisca Abanyie, MD, MPH,b Michael S.D. Agus, MD,c Fran Balamuth, MD, PhD, MSCE,d
Patrick W. Brady, MD, MSc,h Richard J. Brilli, MD, FAAP, MCCM,i Joseph A. Carcillo, MD,j Raymund Dantes, MD,b,k
Lauren Epstein, MD, MSc,b Anthony E. Fiore, MD, MPH,b Jeffrey S. Gerber, MD, PhD,e Runa H. Gokhale, MD, MPH,b
Benny L. Joyner, Jr, MD, MPH,l Niranjan Kissoon, MD, FRCP(C), FAAP, MCCM,m Michael Klompas, MD, MPH,n,o
Grace M. Lee, MD, MPH,p Charles G. Macias, MD, MPH,q Karen M. Puopolo, MD, PhD,f Carmen D. Sulton, MD,r
Scott L. Weiss, MD, MSCE,g Chanu Rhee, MD, MPHn,o
abstractPediatric sepsis is a major public health concern, and robust surveillance tools
are needed to characterize its incidence, outcomes, and trends. The increasing
use of electronic health records (EHRs) in the United States creates an
opportunity to conduct reliable, pragmatic, and generalizable population-level
surveillance using routinely collected clinical data rather than administrative
claims or resource-intensive chart review. In 2015, the US Centers for Disease
Control and Prevention recruited sepsis investigators and representatives of
key professional societies to develop an approach to adult sepsis surveillance
using clinical data recorded in EHRs. This led to the creation of the adult sepsis
event definition, which was used to estimate the national burden of sepsis in
adults and has been adapted into a tool kit to facilitate widespread
implementation by hospitals. In July 2018, the Centers for Disease Control and
Prevention convened a new multidisciplinary pediatric working group to tailor
an EHR-based national sepsis surveillance approach to infants and children.
Here, we describe the challenges specific to pediatric sepsis surveillance,
including evolving clinical definitions of sepsis, accommodation of age-
dependent physiologic differences, identifying appropriate EHR markers of
infection and organ dysfunction among infants and children, and the need
to account for children with medical complexity and the growing
regionalization of pediatric care. We propose a preliminary pediatric
sepsis event surveillance definition and outline next steps for refining and
validating these criteria so that they may be used to estimate the
national burden of pediatric sepsis and support site-specific surveillance to
complement ongoing initiatives to improve sepsis prevention, recognition,
and treatment.
Sepsis is a major cause of death and
disability in patients across the age
spectrum. In May 2017, the United
Nations World Health Assembly and the
World Health Organization adopted as
a global health priority the need to
improve sepsis recognition,
management, and prevention, and,
among other key points, recognized the
substantial toll of sepsis on child
health.1,2 Globally, medical professional
societies and sepsis advocacy
organizations have played an important
role in developing innovative
approaches to improve sepsis care for
adults and children.3 In the United
States, local, state, and national
agencies have targeted sepsis for
quality improvement initiatives. New
York and Illinois, for example,
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established regulations for all
hospitals to implement sepsis
protocols and track compliance in
response to tragic cases of
unrecognized sepsis in children.4,5
More recently, .50 US children’s
hospitals joined the Improving
Pediatric Sepsis Outcomes
collaborative, which aims to reduce
pediatric sepsis mortality by 75%.6
However, as noted by the World
Health Organization sepsis resolution,
there remains a lack of reliable data
and tools to measure pediatric sepsis
incidence, therefore limiting
hospitals’ and regulators’ efforts to
better understand sepsis risk factors,
resource needs, and the impact of
performance-improvement initiatives.
In the United States, researchers of
most epidemiological studies have
used administrative data, which
suggest a substantial rise in sepsis
incidence and a decrease in patient
fatalities over time in both adults and
children.7–11 However, recent studies
in adults reveal that administratively
derived sepsis rates are likely biased
by increased vigilance in sepsis
diagnosis and coding over time.12–14
As clinicians and hospitals screen,
diagnose, and code for sepsis more
aggressively, a larger number of
patients with less-severe illness and
lower mortality are being identified.
However, the impact of such
ascertainment bias on sepsis
epidemiology in children has yet to be
examined. Large-scale studies in
PICUs in which manually abstracted
clinical data are used likely offer more
reliable point prevalence
estimates15,16 but are resource-
intensive, exclude sepsis patients
cared for in non-ICU locations, are
subject to changes in ICU admission
thresholds over time, and are not
practical for longitudinal
epidemiological surveillance.
The increasing national uptake of
electronic health record (EHR)
systems creates an opportunity to
conduct population-level disease
surveillance by using routinely
collected clinical data rather than
administrative data or a manual chart
review. In 2015, the US Centers for
Disease Control and Prevention (CDC)
recruited sepsis experts and
representatives of key professional
societies to develop an approach to
adult sepsis surveillance by using
clinical EHR data. This led to the
establishment of the adult sepsis
event (ASE) surveillance definition,
which was adapted from consensus
clinical criteria and was used to
estimate the national burden of sepsis
in adults.17 The CDC additionally
created a tool kit for hospitals to
employ this surveillance methodology
to monitor the effectiveness of local
sepsis prevention, early recognition,
and treatment programs.18 These
efforts excluded patients ,20 years
old given the important differences in
defining sepsis in infants and children
versus adults.
To address this gap, the CDC
convened a separate working group
in July 2018 that included pediatric
sepsis experts and representatives
from pediatric critical care,
emergency medicine, hospital
medicine, infectious diseases, and
neonatology (Appendix) as well as
the investigators and CDC officials
who developed the ASE surveillance
definition. The working group’s goal
was to propose an agenda for the
development of a reliable, pragmatic,
and generalizable method for
pediatric sepsis surveillance in the
United States, including establishing
a preliminary pediatric sepsis
surveillance case definition and
a plan for its testing and refinement.
From July to October 2018, the CDC
convened working group members
for a series of conference calls in
preparation for an in-person meeting
in Atlanta, Georgia, on November 1,
2018. At the meeting, an initial
proposed approach to pediatric sepsis
surveillance and review of pediatric
organ-dysfunction scoring systems
was presented (H.E.H. and C.R.) as
well as preliminary results from
a single pediatric institution’s
experience with adapting the ASE
methodology to their patient
population (F.B. and S.L.W.). Working
group members were assigned to
small groups and CDC officials
facilitated discussions of each
potential component of a pediatric
sepsis surveillance definition to
identify criteria with clinical face
validity that would be feasible to
incorporate into widespread
surveillance. Here, we summarize the
working group’s considerations,
outline a pediatric sepsis event (PSE)
case definition proposed by working
group members, and describe a road
map for future work needed to refine,





Efforts to standardize sepsis
surveillance in both children and
adults are challenged by ongoing
controversy regarding what
constitutes sepsis and the lack of gold
standard diagnostic criteria. The
1992 and 2001 international
consensus criteria for adults (Sepsis-
1 and Sepsis-2) characterized “sepsis”
as a systemic inflammatory response
syndrome (SIRS) secondary to
infection, with SIRS defined as $2
abnormalities in temperature, heart
rate, respiratory rate, or white blood
cell count, and characterized “severe
sepsis” as sepsis with organ
dysfunction.19,20 These criteria
provided a useful conceptual
framework but yielded low
specificity,21 created semantic
confusion between the terms “sepsis”
and “severe sepsis,” and had limited
applicability to pediatrics given the
age-dependence of normal laboratory
and vital signs values among infants
and young children.22
Acknowledging that children and
adults have different physiology,
immune responses to infection, and
comorbidities, an international panel
convened in 2005 to modify Sepsis-2
criteria for children. The International
Pediatric Sepsis Consensus Criteria
(IPSCC) adopted the Sepsis-2
framework for specified pediatric age
groups and, through expert
consensus, defined sepsis-associated
organ-dysfunction thresholds.22 The
IPSCC provided a consistent
framework for research studies, but it
has not been validated, can be
complex and labor intensive to apply,
and has limited overlap with sepsis
diagnosed at the bedside.23
In 2016, the Third International
Consensus Definitions for Sepsis and
Septic Shock (Sepsis-3) redefined
sepsis in adults as “life-threatening
organ dysfunction due to
a dysregulated host response to
infection.”24,25 This new paradigm
eliminated SIRS because of
insufficient sensitivity and low
specificity for severe infections and
emphasized organ dysfunction as an
essential feature of sepsis. “Septic
shock” was defined as a subset of
sepsis with particularly profound
circulatory, cellular, and metabolic
abnormalities, whereas “severe
sepsis” was considered redundant
and eliminated. Sepsis-3
operationalized measurement of
organ dysfunction as an increase in
the Sequential Organ Failure
Assessment (SOFA) score of $2
points over baseline. Analyses of.1.3
million adult hospitalizations and
external validation in separate data
sets revealed that SOFA scores of
$2 points over baseline had high
predictive validity for death and/or
prolonged ICU stay in patients with
suspected infection.26
Authors of recently published studies
and commentaries support applying
Sepsis-3 to pediatrics but note
the importance of considering the
unique physiology of infants and
children.27–37 As in adults, new or
progressive organ failure is
associated with higher mortality in
children with suspected infections.31
Likewise, SIRS is common in febrile
children who are otherwise well and
correlates poorly with the presence of
infection or sepsis.29,38,39 A recent
study of nearly 2600 children
admitted to PICUs in Australia and
New Zealand revealed that organ-
dysfunction scoring systems
outperformed SIRS criteria for
identifying children at risk for death
or prolonged ICU stay.29 A similar
study in China yielded comparable
results.36
DEFINING SEPSIS FOR SURVEILLANCE
There are multiple purposes for
which sepsis must be defined,





Given the complexity of defining
sepsis, it is unlikely that a single set of
criteria will be able to satisfy all
parameters desired by interested
stakeholders. Stakeholders from each
arena have different priorities and
values that inform their perception of
which evaluation domains should be
prioritized and where along the
spectrum of severity the line should
be drawn to define sepsis (Table 1).
For example, clinicians require
a sepsis definition optimized for
sensitivity, rapid diagnosis, and ease
of real-time application at the bedside
because their goals are early
identification, avoiding missed cases,
and timely treatment. In contrast, the
purpose of public health surveillance
is to reliably track sepsis incidence
and outcomes across settings and
over time to frame public health
policy and research, prioritize
resource allocation, and identify
opportunities to improve prevention
and treatment. Although surveillance
efforts must be clinically credible,
they generally place less emphasis on
timeliness and early identification
and more emphasis on specificity,
objectivity, and reproducibility. This
often means excluding ambiguous or
less-severe cases. Measurement
burden for surveillance should also
TABLE 1 Performance Domains for Sepsis Criteria and Their Priority for Clinical Care Versus
Surveillance
Domain Definition Priority for Different
Applications
Clinical Care Surveillance
Reliabilitya The extent to which a given classification scheme




Timelinessa The speed with which criteria are generated with





Assessment of the relative cost, safety, and
complexity of collecting data incorporated into





Content The extent to which criteria fit with current
understanding and knowledge
High High
Construct The degree to which criteria measure what they
are reported to measure
High High
Criterion The degree to which comparison of the criteria in
question agrees with a related outcome
assessed at the same time or in the future
High High
a In sepsis criteria for clinical care, a high priority should be placed on timeliness and ability to influence real-time
clinical decision-making. Sensitivity is generally emphasized over specificity to avoid missing patients with potential
sepsis. In contrast, the priority for surveillance is objectivity, reproducibility, and suitability for widespread imple-
mentation. For surveillance, specificity is also generally prioritized over sensitivity.
b Measurement burden for clinical care refers to the cost and safety of obtaining diagnostic tests for patients and the
complexity of data interpretation for health care providers. For surveillance, measurement burden reflects the time and
resources required to abstract data and apply case definitions on a population level.
c Criteria for clinical care and surveillance should have at least a moderate overlap but need not match perfectly. The
prognostic value of sepsis criteria for mortality is a major component of criterion validity that is important for both
clinical care and surveillance.
be low to facilitate widespread
implementation. Given the wide-
ranging connotations of the term
“sepsis,” we will use “sepsis event” to
refer to a case identified explicitly for
surveillance.
ASE SURVEILLANCE
The ASE concept was developed by
a multicenter team of investigators to
estimate the national burden of adult
sepsis by using EHR data.17,42,43 The
investigators adapted Sepsis-3
criteria to facilitate wide-scale,
retrospective surveillance, focusing
on clinical indicators of presumed
serious infection and organ
dysfunction that are objective,
routinely measured or used to treat
sepsis, easily ascertainable from
diverse EHRs, and suitable for
consistent and uniform application
across different hospitals.42,43
The ASE case definition defines
presumed serious infection as $1
blood culture draw and concurrent
administration of $4 consecutive
days of antimicrobial agents (fewer if
patients die or are transferred to
hospice or another acute care
hospital) and identifies organ
dysfunction through a modified
version of the SOFA score that
dichotomizes organ dysfunction as
present or absent for each organ
system.17,42 A minimum of 4
antimicrobial days was chosen as
a threshold for presumed infection to
minimize false-positives from
patients who had empirical treatment
stopped when an initially suspected
infection was not confirmed. ASE
thresholds for organ-dysfunction
presence generally correspond to
a SOFA score increase of $2 points
and simplify or eliminate SOFA
components that may be
inconsistently measured,
documented, and stored in EHRs,
such as the Glasgow Coma Scale,44
vital signs,45–47 vasopressor doses,
urine output,48 arterial blood
gases,49,50 and fraction of inspired
oxygen (FIO2) at the time blood gases
are drawn. These changes make the
ASE feasible to reliably measure by
using retrospective data and
applicable across hospitals with
different EHRs that use a common
data specification.43
Validation by using medical record
reviews suggested 70% sensitivity
and a 70% positive predictive value
for the ASE in identifying patients
meeting Sepsis-3 criteria.17 The
positive predictive value reached
88% when sepsis was defined as
organ dysfunction concurrent with
clinically suspected (rather than
confirmed) infection. These
performance characteristics also
compared favorably to administrative
data; explicit diagnosis codes for
severe sepsis or septic shock were
less sensitive (33%) than the ASE but
had a similar positive predictive value
(76%), whereas implicit codes for
infection and organ dysfunction had
comparable sensitivity (66%) but
a lower positive predictive value
(31%). Chart reviews also suggested
that the Sepsis-3 patients missed by
ASE had mild organ dysfunction (such
as mild hypoxemia not requiring
mechanical ventilation) and favorable
prognoses.17 Furthermore, analyses
of large data sets revealed good
concordance between patients
flagged by ASE and Sepsis-3 criteria
and revealed that the ASE organ-
dysfunction criteria had equivalent or
better prognostic accuracy for
mortality than the full SOFA score.51
Applying the ASE definition to EHR
data from a nationally representative
cohort of 409 academic, community,
and federal hospitals from 7
independent data sets indicated that
sepsis was present in 6% of US adult
hospitalizations in 2014 and in one-
third of all hospitalizations
culminating in death.17 Sepsis
incidence and short-term all-cause
mortality (in-hospital death or
discharge to hospice) did not
significantly change between 2009
and 2014, whereas diagnosis codes
from the same hospitals revealed
steady increases in sepsis incidence
and decreases in mortality. In
addition to establishing these
national estimates, the CDC also
released a tool kit to help hospitals
implement the ASE to improve
monitoring of local sepsis
epidemiology and evaluation of the
impact of quality improvement
efforts.18
ADAPTING SEPSIS EVENT
SURVEILLANCE TO PEDIATRICS AND
ESTIMATING NATIONAL PEDIATRIC
SEPSIS BURDEN
The pediatric working group
convened by the CDC agreed that
although the general ASE framework
could be used for pediatric sepsis
surveillance, adapting the adult
approach to infants and children
presented a number of challenges. In
proposing a preliminary PSE
definition, we outline these
challenges as well as our proposed
plan to address them (Table 2). We
also discuss plans for exploring
alternative criteria to optimize case
ascertainment, validating the
proposed definition with chart
review, and applying it to hospitals
across the United States to estimate
the national burden of pediatric
sepsis. We emphasize, however, that
the criteria described are preliminary
and are subject to modification on the
basis of continued refinement during
testing in pediatric data sets. It is also
important to note that the ASE
surveillance scheme was developed
for use in the United States and may
not be generalizable to other
locations with more-limited
resources. This known limitation will
also apply to proposed pediatric
efforts.52
The Sepsis-3 Conceptual Model in
Pediatrics
In anticipation that forthcoming
updated clinical definitions for sepsis
in children will be based on Sepsis-3






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































framework of infection with organ
dysfunction for PSE surveillance and
capturing sepsis events by using EHR
data in a manner similar to the ASE
approach. This consistency will help
minimize confusion that could
otherwise arise from use of different
surveillance frameworks for sepsis
events in children versus adults.
Focusing on severe infections with
concurrent organ dysfunction also
means that tracking PSE incidence
can be helpful for understanding the
impact of upstream sepsis initiatives
that aim to prevent progression to
organ dysfunction, ICU admission, or
death. In the absence of an externally
validated Sepsis-3-aligned pediatric
case definition at this point in time,
we plan to begin with a definition
published by Matics and Sanchez-
Pinto33 as a reference standard for
assessments of the performance of
the PSE definition by using chart
review. An alternative analysis, using
the IPSCC as a reference standard,
may also be pursued,22 and we will
also consider and incorporate other
updated pediatric sepsis definitions
and criteria as they become available.
As described below, we plan to
conduct sensitivity analyses to
further refine the PSE definition to
ensure adequate case ascertainment,
compared with chart review
(Table 2).
Establishing an Appropriate Age
Range for PSE Surveillance
The American Academy of Pediatrics
considers the pediatric population to
range from birth to 21 years of age
but acknowledges that the age cutoff
between pediatric and adult patients
is arbitrary.53 To explore the
transition between adolescence and
adulthood, we plan to assess the
performance of the PSE in
comparison with the ASE for patients
aged 15 to 30 years. In addition,
sepsis surveillance for patients at the
lowest end of the age range requires
special considerations because
clinical practices and conceptual























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































pediatrics.54 Specifically, 2 issues
unique to newborns make it difficult
to adapt the ASE criteria to this
population. First, for infants
,30 days old, a blood culture order
does not signify the same level of
concern for infection as for older
pediatric patients because blood
cultures are routinely obtained from
well-appearing term and preterm
newborns on the basis of infection
risk factors. Second, organ
dysfunction due to developmental
immaturity is common among
preterm newborns and cannot be
readily distinguished from organ
dysfunction due to infection. As
a result, preterm infants often receive
prolonged antimicrobial treatment in
the absence of clear clinical or
microbiologic evidence of infection.
We therefore propose focusing PSE
surveillance on children aged 30 days
to 21 years, additionally excluding all
infants continuously hospitalized
since birth.
Appropriate EHR Capture of
Presumed Serious Infection in
Children
In the ASE surveillance scheme,
a blood culture order, along with
administration of $4 days of
antimicrobial agents, identifies
presumed serious infection.43 We
reached an agreement that blood
culture ordering as a marker of
concern for serious infection applied
similarly to children $30 days old as
to adults because this is also standard
practice for suspected pediatric
sepsis. Likewise, we agreed that
$4 days of antimicrobial agents
represented a reasonable threshold to
start with for distinguishing empirical
treatment of suspected infection from
definitive treatment in children, with
fewer days allowed in the case of
death or transfer to hospice or
another acute care facility. However,
we identified alternative scenarios
that should be explored to optimize
case ascertainment. For example, we
plan to conduct sensitivity analyses to
allow a culture of any body fluid
rather than just blood and to examine
a range of requirements for the
number of antimicrobial days and the
timing of the culture (Table 2). These
scenarios are important to explore
because clinicians may be more
reluctant to draw repeat or multiple
blood cultures in children compared
with adults because of their more-
limited blood volume. This difference
in practice would primarily impact
detection of PSE cases in scenarios in
which a blood culture is obtained in
a community setting and then the
child is transferred to a tertiary care
center for continued management or
in scenarios in which repeat blood
cultures may not be ordered when
new or worsening organ dysfunction
is identified. Therefore, we propose
exploring the impact of removing the
blood culture requirement for
patients transferred from outside
health care facilities who otherwise
meet all other PSE criteria at the
receiving institution. Acknowledging
that some sepsis syndromes in
children may resolve quickly with
appropriate treatment, we also
propose testing the definition with
fewer qualifying antimicrobial days
(ie, $3 days). We also plan to explore
the feasibility of capturing oral
antimicrobial agents prescribed on
discharge, reflecting the scenario in
which children hospitalized with
sepsis rapidly improve with
treatment and are discharged from
the hospital to complete a course of
oral therapy after ,4 days in the
hospital.
Appropriate EHR Capture of Organ
Dysfunction in Children
The IPSCC adaptation of Sepsis-2 to
pediatric populations appropriately
recognized the need for age-
dependent ranges for SIRS criteria.
Likewise, applying the Sepsis-3
framework to pediatrics would
require incorporating age-specific
organ-dysfunction thresholds. There
are a number of candidate organ-
dysfunction scoring systems that
could be incorporated into pediatric
Sepsis-3 criteria, including an age-
adapted variant of SOFA (pediatric
Sequential Organ Failure Assessment
[pSOFA]),33 the Pediatric Logistic
Organ Dysfunction (PELOD-2)
score,55 or the Pediatric Multiple
Organ Dysfunction Score (P-MODS).56
All of these scoring systems were
developed to predict in-hospital
mortality in critically ill children and
account for age-related variation and
were internally validated. The closest
system to the adult SOFA score is the
pSOFA score, which was modified
from the adult SOFA score by using
cutoffs from the PELOD-2 scoring
system and tested by using data from
.6000 critically ill children aged
#21 years old. Pediatric adaptations
within pSOFA include validated age-
dependent cutoffs for the
cardiovascular and renal systems
from PELOD-2, expanded respiratory
criteria that include noninvasive
surrogates of lung injury (ie, use of
pulse oxygen saturation [SpO2]/FIO2
in addition to PaO2/FIO2),
57 and the
pediatric version of the Glasgow
Coma Scale.
Whereas Sepsis-3 uses a SOFA score
of $2 points over baseline to identify
organ dysfunction, the ASE simplifies
this scoring system by dichotomizing
new organ dysfunction as present
versus absent using thresholds that
roughly correspond to $2 SOFA
points. The ASE developers found this
simplified EHR-based implementation
increased feasibility without affecting
prognostic accuracy.51 Following this
paradigm, we propose beginning by
modifying the pSOFA score to
dichotomize new organ dysfunction
and test different scenarios to
determine the optimal threshold
based on associations with outcomes,
correlation with medical record
reviews, and feasibility of extraction
in diverse EHRs. For example, we will
explore definitions with and without
noninvasive positive pressure
ventilation and high-flow oxygen as
surrogates for respiratory failure and
definitions that incorporate fluid-
resuscitation volume as a marker of
persistent hypotension. Adding these
respiratory support modalities and
fluid parameters may increase the
clinical relevance of a surveillance
definition but may come at the cost of
added complexity or diminished
generalizability across EHRs.58 In
addition, given that pSOFA has not
been independently validated, we will
explore the impact of a number of
changes that would allow the PSE
criteria to more closely mirror the
PELOD-2 or P-MODS scoring systems
rather than pSOFA. For example,
hepatic dysfunction did not reach the
threshold for inclusion in the PELOD-
2 score,55 did not predict death in the
P-MODS,56 and may rarely be the sole
manifestation of sepsis in
pediatrics.16 Therefore, it may be less
useful as a surveillance criterion.
Hyperlactatemia, however, is included
in both the PELOD-2 score and the
P-MODS. As such, we will explore the
impact of eliminating hepatic
dysfunction or adding lactate as case-
ascertainment criteria.
Accounting for Heterogeneity in
Pediatric Populations and Locations
of Care
Any approach to pediatric sepsis
surveillance in the United States
should account for the heterogeneity
of pediatric populations with respect
to age, race and/or ethnicity,
comorbidities, and level and locations
of care. When comparing PSE case
ascertainment to chart review, we
will identify each patient’s age, sex,
race and/or ethnicity, comorbidities,
and other relevant clinical
characteristics (location of care,
sepsis present on admission versus
hospital onset, ICU admission,
hospital length of stay, and discharge
disposition). This will allow us to
assess the ability of the PSE approach
to appropriately capture pediatric
patients with different characteristics.
In particular, it is vital to recognize
the rising prevalence of children with
medical complexity,59–61 defined as
infants, children and young adults
with serious chronic conditions,
substantial functional limitations,
and/or increased health and other
service needs.60 To ensure that the
PSE definition appropriately
identifies sepsis both in children who
were previously healthy and those
with medical complexity, we plan to
use the pediatric complex chronic
conditions classification system62 to
identify patients with baseline
technology dependence or organ
dysfunction. We will then conduct
targeted chart reviews of patients
with $1 and $2 complex chronic
conditions to ensure adequate
capture of new or worsening organ
dysfunction and sepsis in these
patients with medical complexity.
In addition, a national approach to
pediatric sepsis surveillance should
also account for the increasing
regionalization of health care (ie, the
growing concentration of care at
larger referral centers), which affects
infants and children to an even
greater extent than adults.63–65 As
such, the development and validation
process for the PSE and the proposed
subsequent study to estimate the
national burden of pediatric sepsis
must incorporate data from children’s
hospitals, larger general academic
medical centers, and community
hospitals, where both previously well
children and children with medical
complexity may initially present
before transfer or stay to receive
definitive care. We plan to conduct
targeted chart reviews to ensure
adequate capture of sepsis cases in
children transferred to and from
these facilities.
Road Map for Future Work
The scope of future directions
proposed by our working group is
ambitious and broad. It includes (1)
refining and validating a PSE case
definition that can accommodate
diverse EHRs; (2) conducting
a multicenter, national study to
estimate the burden of pediatric
sepsis in the United States by using
EHR data; and (3) developing a tool
kit that can be used by hospitals to
implement PSE surveillance. This
work will require time, funding, and
effort. Once a tool kit is developed,
the incorporation of PSE surveillance
into routine hospital operations will
then require buy-in from local
clinicians and administrators as well
as substantial effort from informatics
teams. However, the experience
of using shared code and a common
data specification to apply the
ASE to 409 hospitals from 7
separate data sets derived from
different EHRs suggests that it is
feasible and can yield valuable
information on sepsis incidence
and outcomes.66
CONCLUSIONS
Pediatric sepsis is a major public
health concern, and robust
surveillance tools are needed to
characterize its burden, outcomes,
and trends. The increasing uptake of
EHRs throughout the United States
allows for the possibility of
surveillance that uses objective
clinical data rather than
administrative claims or a manual
chart review. A pediatric surveillance
definition based on EHR data could
use the framework of the ASE
definition but requires adaptation to
address specific differences and
challenges in the pediatric
population. A nationally
representative study of pediatric
sepsis incidence, outcomes, and
trends in which EHR data are
used would shed light on the
impact of recent initiatives to
improve sepsis recognition and
management and would help identify
additional priorities for intervention.
A PSE tool kit could also support
site-specific surveillance that
would complement ongoing
pediatric sepsis quality improvement
efforts. Ultimately, our vision
would be for local and national
PSE surveillance data to be used
by clinicians, quality officers,
policy-makers, and public health
officials to further drive
innovation and improvements
in the prevention, detection,
and management of pediatric
sepsis.
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